|
CCDC6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.556200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.195590E-03 |
| Normal-vs-Stage2 |
5.630800E-04 |
| Normal-vs-Stage3 |
2.619000E-03 |
| Normal-vs-Stage4 |
2.405500E-02 |
| Stage1-vs-Stage2 |
2.467800E-01 |
| Stage1-vs-Stage3 |
8.590400E-01 |
| Stage1-vs-Stage4 |
9.164400E-01 |
| Stage2-vs-Stage3 |
3.443400E-01 |
| Stage2-vs-Stage4 |
3.377200E-01 |
| Stage3-vs-Stage4 |
8.345000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.183060E-03 |
| Normal-vs-AfricanAmerican |
4.593200E-01 |
| Normal-vs-Asian |
4.696600E-03 |
| Caucasian-vs-AfricanAmerican |
1.393790E-01 |
| Caucasian-vs-Asian |
5.431200E-01 |
| AfricanAmerican-vs-Asian |
1.070950E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.191980E-02 |
| Normal-vs-Female |
2.430600E-04 |
| Male-vs-Female |
1.990360E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.961960E-02 |
| Normal-vs-Age(41-60Yrs) |
1.031370E-04 |
| Normal-vs-Age(61-80Yrs) |
1.136220E-03 |
| Normal-vs-Age(81-100Yrs) |
1.041650E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.390400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.300600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.431600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.778200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.274800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.871200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.831030E-01 |
| Classical-VS-Follicular |
7.88650000000946E-05 |
| Classical-VS-Other |
5.523000E-01 |
| Classical-VS-Normal |
8.255900E-03 |
| Tall-VS-Follicular |
2.573600E-04 |
| Tall-VS-Other |
2.168600E-01 |
| Tall-VS-Normal |
4.972000E-01 |
| Follicular-VS-Other |
5.016600E-01 |
| Follicular-VS-Normal |
3.05449999959961E-07 |
| Other-VS-Normal |
1.136840E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.31269999997996E-06 |
| Normal-vs-N1 |
6.035900E-04 |
| N0-vs-N1 |
9.152200E-01 |
|
|
